Voyager Therapeutics (VYGR) Retained Earnings (2014 - 2026)
Voyager Therapeutics recorded quarterly Retained Earnings of -$263000.0 in Q1 2026, down 921.88% quarter-over-quarter from $32000.0 in Q4 2025, and up 99.93% year-over-year from -$131548.4 in Q1 2025.
Voyager Therapeutics' Retained Earnings history runs 13 years deep, the most recent figure standing at -$263000.0 for Q1 2026.
- In Q1 2026, Retained Earnings rose 99.93% year-over-year to -$263000.0; the TTM figure through Mar 2026 stood at -$263000.0 (up 99.93% YoY), while the FY2025 annual figure was $32000.0, up 107.86% from the prior year.
- Retained Earnings came in at -$263000.0 for Q1 2026 at Voyager Therapeutics, down from $32000.0 in the prior quarter.
- In the past five years, Retained Earnings ranged from a high of $32000.0 in Q4 2025 to a low of -$418.5 million in Q3 2025.
- A 5-year average of -$201.9 million and a median of -$282.7 million in 2024 frame the typical range for Retained Earnings.
- Across the five-year window, Retained Earnings plunged 307439.68% in 2022 and surged 107.86% in 2025, its largest moves.
- Voyager Therapeutics' Retained Earnings stood at -$219000.0 in 2022, then jumped by 78.08% to -$48000.0 in 2023, then slumped by 747.92% to -$407000.0 in 2024, then jumped by 107.86% to $32000.0 in 2025, then slumped by 921.88% to -$263000.0 in 2026.
- According to Business Quant data, Retained Earnings over the past three periods registered -$263000.0, $32000.0, and -$418.5 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | -211.85 Mn |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | -153.89 Mn |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | 1.00 Bn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | -438.66 Mn |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | -279.00 Mn |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 14.59 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | 130.89 Mn |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | 36.42 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | -24.89 Mn |
| 10 | Voyager Therapeutics | 230.25 Mn | 88.77 Mn | - | -263,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -263,000.00 |
| Dec 31, 2025 | 32,000.00 |
| Sep 30, 2025 | -418.48 Mn |
| Jun 30, 2025 | -390.59 Mn |
| Mar 31, 2025 | -357.20 Mn |
| Dec 31, 2024 | -407,000.00 |
| Sep 30, 2024 | -291.70 Mn |
| Jun 30, 2024 | -282.70 Mn |
| Mar 31, 2024 | -272.51 Mn |
| Dec 31, 2023 | -48,000.00 |
| Sep 30, 2023 | -248,000.00 |
| Jun 30, 2023 | -291.68 Mn |
| Mar 31, 2023 | -132,000.00 |
| Dec 31, 2022 | -219,000.00 |
| Sep 30, 2022 | -369.89 Mn |
| Jun 30, 2022 | -387.50 Mn |
| Mar 31, 2022 | -368.40 Mn |
| Dec 31, 2021 | -347.10 Mn |
| Sep 30, 2021 | -352.80 Mn |
| Jun 30, 2021 | -126,000.00 |
| Mar 31, 2021 | -297.60 Mn |
| Dec 31, 2020 | -134,000.00 |
| Sep 30, 2020 | -259.98 Mn |
| Jun 30, 2020 | 145,000.00 |
| Mar 31, 2020 | 421,000.00 |
| Dec 31, 2019 | -104,000.00 |
| Sep 30, 2019 | -300.07 Mn |
| Jun 30, 2019 | 101,000.00 |
| Mar 31, 2019 | -75,000.00 |
| Dec 31, 2018 | -269.05 Mn |
| Sep 30, 2018 | -174,000.00 |
| Jun 30, 2018 | -226.23 Mn |
| Mar 31, 2018 | -200.69 Mn |
| Dec 31, 2017 | -287,000.00 |
| Sep 30, 2017 | -455,000.00 |
| Jun 30, 2017 | -125.54 Mn |
| Mar 31, 2017 | -106.66 Mn |
| Dec 31, 2016 | -90.02 Mn |
| Sep 30, 2016 | 630,000.00 |
| Jun 30, 2016 | -66.35 Mn |
| Mar 31, 2016 | -57.01 Mn |
| Dec 31, 2015 | -49.82 Mn |
| Sep 30, 2015 | 38,000.00 |
| Dec 31, 2014 | -20.83 Mn |